相关实验视频

Updated: Jun 29, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

在NAFLD/NASH中使用西利马林:系统性审查和元分析

Shudi Li¹, Fei Duan², Suling Li²

¹The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.

Annals of hepatology

|April 5, 2024

概括

补充西利玛林可显著改善非酒精性脂肪肝疾病 (NAFLD) 患者的脂质样本,肝酶和肝脏组织学. 需要进一步的研究来证实西利马林对NAFLD管理的有益影响.

科学领域:

肝病学和胃肠道学
营养科学营养科学
基于证据的医学基于证据的医学.

背景情况:

非酒精性脂肪性肝病 (NAFLD) 是一种常见的慢性肝病,对健康有重大影响.
营养补充剂减轻NAFLD进展的潜力是积极研究的领域.
乳提取物西利马林以其肝脏保护性而闻名,但其在NAFLD中的特定作用需要澄清.

结论:

在NAFLD患者中,西利玛林显示出调节能量代谢和减轻肝损伤的能力.
提取物还显示出改善肝脏组织学,特别是肝脏肥胖症的前景.
建议进行进一步的临床研究,以验证和巩固西利马林在NAFLD中的治疗作用.

关键词:

人类测量参数人类测量参数能量代谢能量代谢肝脏组织学变化肝脏组织学变化肝脏损伤肝脏损伤是什么?这是NAFLD.

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

相关概念视频

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...